SAC Capital adds to position in ARIAD Pharmaceuticals (ARIA)
Posted on April 27th, 2012
SAC Capital has just put out a new Schedule 13G disclosing ownership in 7,876,700 shares of ARIA as of April 17th. This gives SAC 4.9% ownership in ARIA and is an increase of 5,325,375 shares over their last reported position on 12/31/2011.
ARIAD Pharmaceutials is an oncology company focusing on the discovery, development, and commercialization of medicines for cancer patients.
SAC Capital is a Connecticut based hedge fund found by Steven Cohen in 1992.
Reported via | Date | Name | Ticker | Shares | % of Portfolio |
---|---|---|---|---|---|
13F | 2009-12-31 | Ariad Pharmaceuticals Inc. | ARIA | 76,892 | 0.00 |
13F | 2010-09-30 | Ariad Pharmaceuticals Inc. | ARIA | 600 | 0.00 |
13F | 2011-03-31 | Ariad Pharmaceuticals Inc. | ARIA | 18,285 | 0.00 |
13F | 2011-06-30 | Ariad Pharmaceuticals Inc. | ARIA | 109,578 | 0.01 |
13F | 2011-09-30 | Ariad Pharmaceuticals Inc. | ARIA | 176,796 | 0.01 |
13F | 2011-12-31 | Ariad Pharmaceuticals Inc. | ARIA | 2,551,325 | 0.20 |
SC 13G | 2012-04-27 | Ariad Pharmaceuticals Inc. | ARIA | 7,876,700 | N/A |